WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 $
arrow_upward
+0,48%(+0,060) 1D
16 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WXXWY...
Open
12,29 $
High
12,56 $
Low
12,20 $
Mkt. cap
198,43 մլրդ
Avg. vol.
61,89 հզր
Volume
110,85 հզր
52-wk high
14,80 $
52-wk low
7,30 $
Beta
0,01
Shares outstanding
2,06 մլրդ
No. of employees
15 հզր
Open
12,29 $
High
12,56 $
Low
12,20 $
Mkt. cap
198,43 մլրդ
Avg. vol.
61,89 հզր
Volume
110,85 հզր
52-wk high
14,80 $
52-wk low
7,30 $
Beta
0,01
Shares outstanding
2,06 մլրդ
No. of employees
15 հզր
News stories
From web sources and news partners
TradingView
·
21 րոպե առաջ
No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious
BigGo Finance
·
23 րոպե առաջ
South Korea's FSS Chief Says Solidigm's Nasdaq Listing Would Constitute Duplicate Listing, Hints at Conveying Concerns to SK Hynix
Bloomberg.com
·
6 ժամ առաջ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics Cayman ADR